Vaccine for cervical cancer virus passes 1st safety test
Government scientists report a potential HPV vaccine has passed its first human safety test. Experts call the early results promising as researchers plan years more trials to confirm protection against cervical cancer. Mammoth global toll and Pap test role highlighted by officials and researchers.
MENTIONED IN THIS ARTICLE
Washington
Harald Zur Hausen
Heidelberg
Germany
Digene Corp
NCI
Diane Solomon
Solomon
Also Mentioned on This Page
Journal of the National Cancer Institute
Digene
Developing Countries
United States
Thomas
Norvaha
Amy Phillips Medical Fund
Aegis Middle School
Prairie Dr
New Cedar Rapids
Cedar Rapids
Tues
Sheraton
Four Points
33Rd Ave
S.W
Loseweightseminar
Debbie Kersh
Texas
Ckcr
LYN
Ronald B. Gorayeb
Kearney
Riverside
Elaine Burrows
Liverpool
Springtown
Albert Grenos
Somers
Grace Heatley
Weatherford
GS Inc
1St Ave
Mt. Vernon Rd
E. Collins Rd
Marlboro
Virginia Slims
Budweiser
BUD Light
Diab
Per Carton
Leinenkugel
Doral Basic
Cambridge
Icehouse
Kwiktrip.com
Sola Optical USA
Iowa Eye Center
Opel
First Avenue